Target intelligence / Profile preview

FimH adhesin (Escherichia coli) (FimH)

Target
FimH
Molecular classification
Adhesin, Bacterial surface protein, Non-enzymatic microbial virulence factor
01

Overview

FimH is a bacterial adhesin protein found at the tip of type 1 fimbriae in Escherichia coli. It specifically binds to mannose residues on host cell glycoproteins and is a major determinant of E. coli’s ability to attach to and colonize epithelial surfaces, notably in the urinary tract. FimH plays a critical role in the pathogenesis of urinary tract infections and contributes to biofilm formation, making it a validated target for anti-adhesion drugs and vaccines. The FimH adhesin features a double-domain structure: a mannose-binding lectin domain and a pilin domain that anchors it to the fimbria. Mutations in FimH can alter binding characteristics and enhance virulence. Targeted pharmacological inhibition or immunization against FimH disrupts bacterial adhesion and is under investigation for preventing E. coli infections

Other names
Type 1 fimbrial adhesinMannose-specific adhesinFimH protein
02

Mechanism of action

Competitive inhibition (occupying the mannose-binding pocket to prevent adhesion); Allosteric inhibition (stabilizing non-adhesive FimH conformations); Vaccine-induced antibody response targeting FimH

03

Biological functions

Mediates bacterial adhesion to host cells and abiotic surfacesFacilitates colonization of urinary tract and other tissuesInitiates biofilm formationPromotes host-pathogen interactions
04

Disease associations

Infection (especially urinary tract infection)Biofilm-related antimicrobial resistancePathogenic colonization
05

Safety considerations

Potential for bacterial resistance via FimH mutationOff-target effects if targeting structurally similar adhesins in beneficial microbiota
06

Interacting drugs

FimH antagonists/inhibitors (e.g., mannose-based compounds, small molecule glycomimetics, vaccine candidates)
07

Biomarkers

FimH expression (for pathogenic E. coli in urinary tract infection and colonization studies)

Beyond the preview

Go deeper on FimH adhesin (Escherichia coli) (FimH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FimH adhesin (Escherichia coli) (FimH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call